Lisata Therapeutics Inc (NASDAQ:LSTA), a clinical-stage pharmaceutical companies developing innovative therapies for advanced solid tumors and other serious diseases, said management would be participating in several upcoming industry and investor events.
The company will be presenting at the BIO International Convention being held in San Diego, California from June 3 to 6 and the virtual GCFF 2024 Bio Investing Conference on June 20.
More information about the events can be found here.